Patents by Inventor Shusaburo Hokukoku

Shusaburo Hokukoku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6171805
    Abstract: A DNA encoding a cell surface polypeptide of Porphyromonas gingivalis, and a recombinant DNA being a DNA having integrated said DNA thereinto. The cell surface polypeptide of the periodontopathic organism useful for prophylaxis and diagnosis of periodontal diseases can be obtained in a large amount by a microorganism containing the recombinant DNA wherein the DNA was integrated.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: January 9, 2001
    Assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Medex Co., Ltd,, Meito Sangyo Kabushiki Kaisha
    Inventors: Hideharu Mori, Mamoru Hasegawa, Masanori Fukui, Kenji Yasuda, Keiko Yamada, Shusaburo Hokukoku, Tomohiko Ogawa
  • Patent number: 5948636
    Abstract: A DNA encoding a cell surface polypeptide of Porphyromonas gingivalis, and a recombinant DNA being a DNA having integrated the encoding DNA thereinto. The cell surface polypeptide of the periodontopathic organism useful for prophylaxis and diagnosis of periodontal diseases can be obtained in a large amount by a microorganism containing the recombinant DNA wherein the DNA was integrated.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: September 7, 1999
    Assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Medex Co., Ltd., Meito Sangyo Kabushiki Kaisha
    Inventors: Hideharu Mori, Mamoru Hasegawa, Masanori Fukui, Kenji Yasuda, Keiko Yamada, Shusaburo Hokukoku, Tomohiko Ogawa
  • Patent number: 5766572
    Abstract: A water-soluble carboxypolysaccharide-magnetic iron oxide complex of small particle diameter composed of a water-soluble carboxypolysaccharide and a magnetic iron oxide having a core diameter ranging from about 2 to about 7 nm, wherein the total diameter ranges from about 10 to about 50 nm, the ratio of the total diameter to the core diameter is about 15 or less, and the T.sub.2 -relaxivity ranges from about 10 to about 150 (mM.sec).sup.-1. Said complex has low toxicity and small side effects and is useful in the fields of medical treatment, biology and engineering as an iron-supplementing agent, an X-ray contrast medium, an MRI contrast medium, a reagent for blood flow rate measurement, a carrier for drug administration, etc.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: June 16, 1998
    Assignee: Meito Sangyo Kabushiki Kaisha
    Inventors: Masakatsu Hasegawa, Yoshio Ito, Hisato Yamada, Hideo Nagae, Nahoko Tozawa, Yukari Hino, Kyoji Kito, Shusaburo Hokukoku, Rudiger Lawaczeck, Wolfgang Ebert, Detlef Pfefferer, Susanne Wagner, Mayk Kresse
  • Patent number: 5424419
    Abstract: An oxidized complex comprising a water-soluble carboxypolysaccharide and magnetic iron oxide, which is characterized by being obtained by oxidizing a complex comprising a water-soluble carboxypolysaccharide and magnetic iron oxide. Said oxidized complex has very low toxicity, is very stable, exhibits little or no blood pressure-reducing action and has low platelets-aggregating action when administered directly into the blood vessels of animals, and is useful in medical fields such as contrast medium for magnetic resonance imaging, exothermic medium for hyperthermia and the like.
    Type: Grant
    Filed: February 11, 1993
    Date of Patent: June 13, 1995
    Assignee: Meito Sangyo Kabushiki Kaisha
    Inventors: Masakatsu Hasegawa, Hideo Nagae, Yoshio Ito, Akihiro Mizutani, Kimio Hirose, Masahiro Ohgai, Yasuji Yamashita, Nahoko Tozawa, Keiko Yamada, Kyoji Kito, Shusaburo Hokukoku
  • Patent number: 5328681
    Abstract: A composition containing magnetic metal oxide ultrafine particles, which comprises an aqueous sol of a complex of the magnetic metal oxide ultrafine particles with a polysaccharide, a polysaccharide derivative and/or a protein; and an organic monocarboxylic acid. The composition is free of side effects such as platelet aggregation, is safe for use with living bodies, and, in the case of intravascular administration, has no harmful effects on living bodies, and is useful in fields such as medicine and diagnostic drugs.
    Type: Grant
    Filed: September 17, 1992
    Date of Patent: July 12, 1994
    Assignee: Meito Sangyo Kabushiki Kaisha
    Inventors: Kyoji Kito, Hideo Nagae, Masakatsu Hasegawa, Yoshio Ito, Akihiro Mizutani, Kimio Hirose, Yasuji Yamashita, Nahoko Tozawa, Keiko Yamada, Masahiro Ohgai, Shusaburo Hokukoku
  • Patent number: 4983725
    Abstract: Novel mannobiose derivative represented by the general formula [I]: ##STR1## wherein groups of R.sub.1 to R.sub.5 each represents --OH, --OR.sub.6, --NHR.sub.6, (R.sub.6 represents an acyl group) or a group represented by the following formula (a), (b), (c), (d) or (e), provided that one of R.sub.1 to R.sub.5 represents --OR.sub.6 or --NHR.sub.6, one of the other 4 groups of R.sub.1 to R.sub.5 represents one of the groups represented by the formulae (a) to (e), and the remaining 3 groups of R.sub.1 to R.sub.5 represent --OH: ##STR2## wherein represents .alpha. or .beta. bond are provided by the invention.These compounds give liposomes a specific affinity for Kupffer cells of liver, and can be produced industrially.
    Type: Grant
    Filed: March 31, 1988
    Date of Patent: January 8, 1991
    Assignees: Meito Sangyo Co., Ltd., Daiichi Seiyaku Co., Ltd.
    Inventors: Hideki Miyaji, Shusaburo Hokukoku, Munehiro Tomikawa, Sadao Hirota, Hiroshi Kikuchi